ZNF887P: A Drug Target / Disease Biomarker (G100419709)

Target Name: ZNF887P

NCBI ID: G100419709

ZNF887P

Other Name(s): ZNF887 | Zinc finger protein 887, pseudogene | zinc finger protein 887, pseudogene

ZNF887P: A Drug Target / Disease Biomarker

ZNF887P is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. ZNF887P is a member of the ZNF family, which is known for its role in regulating gene expression and cell proliferation.

The ZNF887P gene has been shown to play a role in the development and progression of various diseases. For example, studies have shown that individuals with certain genetic variations in the ZNF887P gene are at an increased risk of developing neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Additionally, ZNF887P has also been associated with the development of certain psychiatric disorders, such as depression and anxiety. This is because the ZNF887P gene has been shown to play a role in the regulation of neurotransmitter synthesis and release, which is important for the functioning of the brain.

Despite these promising findings, more research is needed to fully understand the role of ZNF887P in disease. For example, it is still unclear whether targeting ZNF887P with drugs will be effective in treating these diseases. However, research is ongoing, and as more studies are conducted, it is likely that we will gain a better understanding of the role of ZNF887P in disease.

In conclusion, ZNF887P is a gene that has the potential to be a drug target or biomarker for various diseases. Further research is needed to fully understand its role in disease and to develop effective treatments.

Protein Name: Zinc Finger Protein 887, Pseudogene

The "ZNF887P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF887P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets